Targeting the Human T-Cell Inducible COStimulator Molecule with a Monoclonal Antibody Prevents Graft-vs-Host Disease and Preserves Graft vs Leukemia in a Xenograft Murine Model-Reference-Cited by-同舟云学术

Targeting the Human T-Cell Inducible COStimulator Molecule with a Monoclonal Antibody Prevents Graft-vs-Host Disease and Preserves Graft vs Leukemia in a Xenograft Murine Model

Published:2017-06-30 Issue: Volume:8 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Burlion Aude,Brunel Simon,Petit Nicolas Y.,Olive Daniel,Marodon Gilles

Funder

Agence Nationale de la Recherche

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference39 articles.

1. Would suicide gene therapy solve the “T-cell dilemma” of allogeneic bone marrow transplantation?;Cohen;Immunol Today,1999

2. CD28-specific antibody prevents graft-versus-host disease in mice;Yu;J Immunol,2000

3. ICOS is an inducible T-cell co-stimulator structurally and functionally related to CD28;Hutloff;Nature,1999

4. T-cell co-stimulation through B7RP-1 and ICOS;Yoshinaga;Nature,1999

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. High dimensional proteomic mapping of bone marrow immune characteristics in immune thrombocytopenia;Science China Life Sciences;2024-04-19

2. Comprehensive analysis of the role of ICOS ( CD278 ) in pan-cancer prognosis and immunotherapy;BMC Cancer;2023-02-28

3. Insights and strategies to promote immune tolerance in allogeneic hematopoietic stem cell transplantation recipients;Translational Autoimmunity;2023

4. Change in Programmed Death-1 And Inducible Costimulator Expression in Patients with Acute Myeloid Leukemia Following Chemotherapy and Its Cytogenetic Abnormalities;Galen Medical Journal;2022-12-31

5. Inducible Co-Stimulator (ICOS) in transplantation: A review;Transplantation Reviews;2022-12